To detect allergic bronchial asthma to Dermatophagoides pteronyssinus and its frequency in a group of asthmatics, a study was carried out in 800 asthmatic patients and 345 healthy subjects from seven different areas of the country. We considered only allergic bronchial asthma to Dermatophagoides pt. without taking into consideration other allergens. Patients with chronic bronchopathy were not included in the study. The average frequency of disease in the group investigated was of 32 per cent. Considering the high frequency of this form of allergic bronchial asthma, specialists should grant a special attention to the early detection and treatment of this disease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

allergic bronchial
16
bronchial asthma
16
asthma dermatophagoides
12
dermatophagoides pteronyssinus
8
frequency
4
frequency allergic
4
bronchial
4
asthma
4
pteronyssinus areas
4
areas romania
4

Similar Publications

Background: Cough variant asthma (CVA) is a specific type of asthma characterized by chronic cough as the sole or predominant symptom. Accurate diagnosis is crucial for effective treatment, yet bronchial provocation test is not always feasible in clinical settings. To identify independent predictors of CVA diagnosis, we developed a nomogram for predicting CVA.

View Article and Find Full Text PDF

Background: The incidence of allergic diseases has been increasing in Japan. In particular, a serious decline in the age of onset of allergic rhinitis has been observed. Passive smoking from parental smoking has a significant impact on children's health; however, it is difficult to restrict smoking in the home.

View Article and Find Full Text PDF

Silibinin alleviates house dust mite induced allergic airway inflammation by inhibiting NLRC4 inflammasome and MMP-9 expression.

Biomed Pharmacother

January 2025

College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, 77 Yong-bong-ro, Buk-gu, Gwangju 61186, Republic of Korea. Electronic address:

Silibinin, a major compound of silymarin, has been reported to alleviate respiratory diseases including acute lung injury, asthma, chronic obstructive pulmonary disease, and pulmonary fibrosis through its antifibrotic, anti-inflammatory, and antioxidant properties. However, the specific mechanisms underlying its therapeutic effects, particularly in allergic asthma, are not fully understood. With the increasing prevalence and impact of allergic asthma, there is a need to elucidate the exact underlying mechanisms of its potential treatment effects.

View Article and Find Full Text PDF

Substantial epidemiological evidence suggests a significant correlation between particulate matter 2.5 (PM) and lung cancer. However, the mechanism underlying this association needs to be further elucidated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!